BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15535738)

  • 1. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring.
    Kirkpatrick ND; Zou C; Brewer MA; Brands WR; Drezek RA; Utzinger U
    Photochem Photobiol; 2005; 81(1):125-34. PubMed ID: 15535738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts.
    Zou C; Brewer M; Cao X; Zang R; Lin J; Deng Y; Li C
    Gynecol Oncol; 2007 Dec; 107(3):441-9. PubMed ID: 17854871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents.
    Brewer M; Utzinger U; Li Y; Atkinson EN; Satterfield W; Auersperg N; Richards-Kortum R; Follen M; Bast R
    J Biomed Opt; 2002 Jan; 7(1):20-6. PubMed ID: 11818008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.
    Brewer M; Utzinger U; Satterfield W; Hill L; Gershenson D; Bast R; Wharton JT; Richards-Kortum R; Follen M
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):889-93. PubMed ID: 11489756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
    Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric retinoid prodrug PG-4HPR enhances the radiation response of lung cancer.
    Zhu G; Cao X; Chang JY; Milas L; Wallace S; Li C
    Oncol Rep; 2007 Sep; 18(3):645-51. PubMed ID: 17671714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
    Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
    Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
    Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Rac in fenretinide-induced apoptosis.
    Kadara H; Tahara E; Kim HJ; Lotan D; Myers J; Lotan R
    Cancer Res; 2008 Jun; 68(11):4416-23. PubMed ID: 18519704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production.
    Andrews WJ; Winnett G; Rehman F; Shanmugasundaram P; Hagen Dv; Schrey MP
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):159-65. PubMed ID: 15862961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
    Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells.
    Barna G; Sebestyén A; Weischede S; Peták I; Mihalik R; Formelli F; Kopper L
    Anticancer Res; 2005; 25(6B):4179-85. PubMed ID: 16309214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo monitoring the changes of interstitial pH and FAD/NADH ratio by fluorescence spectroscopy in healing skin wounds.
    Mokrý M; Gál P; Vidinský B; Kusnír J; Dubayová K; Mozes S; Sabo J
    Photochem Photobiol; 2006; 82(3):793-7. PubMed ID: 16435883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus macaque model for ovarian cancer chemoprevention.
    Brewer M; Baze W; Hill L; Utzinger U; Wharton JT; Follen M; Khan-Dawood F; Satterfield W
    Comp Med; 2001 Oct; 51(5):424-9. PubMed ID: 11924802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.
    Kouhara J; Yoshida T; Nakata S; Horinaka M; Wakada M; Ueda Y; Yamagishi H; Sakai T
    Int J Oncol; 2007 Mar; 30(3):679-87. PubMed ID: 17273769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased level of the p67phox subunit of NADPH oxidase by 4HPR in head and neck squamous carcinoma cells.
    Kim HJ; Oridate N; Lotan R
    Int J Oncol; 2005 Sep; 27(3):787-90. PubMed ID: 16077929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.